Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
Boston Scientific announced a $138 million investment to build a 500,000‑square‑foot distribution center in Plainfield, Indiana. The facility will house advanced logistics, light‑manufacturing and regulatory‑compliance capabilities, creating up to 300 high‑wage jobs. Construction is slated to begin later this year, positioning the plant as a global hub for the company’s medical devices that serve over 48 million patients annually. The project aligns with Indiana’s broader $1 billion, ten‑year life‑science growth plan.
If Your AI Can’t Explain Itself, Can FDA Authorize It?
Manufacturers are encountering FDA deficiency letters on AI‑driven diagnostic tools despite high accuracy because reviewers cannot understand how the algorithms work. The agency now emphasizes explainability, requiring clear documentation of model logic, data provenance, and clinical interpretability under Good Machine...
Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
Hospitals rely on real‑time Medicaid eligibility data to decide whether costly medical devices, imaging, or digital therapeutics will be reimbursed. In FY 2024, improper Medicaid payments reached roughly $31.1 billion, a 5.09 % error rate driven largely by incomplete enrollment verification. Fragmented eligibility...
The Failure of the ‘Usual Suspects’ Approach to Life Science Recruitment
The article argues that the traditional "usual suspects" executive search model is failing to meet the talent needs of AI‑driven clinical diagnostics firms. With the global AI diagnostics market projected to reach $10.1 billion in 2026 and $209.6 billion by 2034, the...
Value, Focus, and the Future of MedTech: M&A and Divestitures Are Rewriting the Strategic Playbook.
MedTech firms are reshaping portfolios by prioritizing market access, turning it into the primary driver of mergers, acquisitions and divestitures. Leaders now evaluate assets on reimbursement certainty, evidence strength and ASP durability rather than pure innovation. High‑profile deals such as...
The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-Escalation
Boston Children’s Hospital has spent over a decade deploying AI‑driven clinical intelligence in its pediatric ICUs, shifting the focus from early‑warning alerts to data‑backed de‑escalation. Continuous, high‑frequency physiologic monitoring now provides real‑time risk trajectories that inform decisions on extubation and...
Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
Medtronic announced a sweeping restructuring of its cardiovascular business, including the planned closure of its Santa Rosa, California campus, which will affect roughly 370 employees. The company merged its cardiac surgery and aortic units into a new Cardiovascular Surgery operating...
The Hidden Design Flaw in Medical Device Service Technology
Medical device service platforms still rely on industrial‑style metrics such as uptime and ticket closure, which ignore the regulatory and safety dimensions of clinical equipment. In regulated health settings, a device must be demonstrably ready for patient use, with real‑time...
An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
For six decades the ventriculoperitoneal shunt has been the standard treatment for hydrocephalus, but its invasive nature and high complication rates limit patient eligibility. Endovascular neurosurgery, refined through stroke and aneurysm care, now enables catheter‑based shunt placement that avoids craniotomy....
Why Gen AI Is a Win for MedTech: And, How to Unlock Its Potential with the Right Policies
Generative AI is rapidly becoming a core productivity tool in medical device development, accelerating tasks such as code generation, unit testing and especially documentation. Studies show AI can reduce unit‑testing effort by up to 70%, while AI‑drafted design artifacts free...
Maintaining Trust in Medical AI: Monitoring and Managing Model Lifecycle
Artificial intelligence is becoming integral to health‑tech, powering diagnostics, decision support and patient management. However, models trained on historic data can lose accuracy as patient populations, clinical practices and data capture evolve. The article explains data drift (shifts in input...
Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
Sonire Therapeutics announced the launch of SUNRISE‑II, its first U.S. clinical trial evaluating a proprietary high‑intensity focused ultrasound (HIFU) system for pancreatic cancer. The study will enroll roughly 10 patients to assess safety and feasibility. The inaugural patient was treated...
Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
Medtronic announced the completion of its $585 million acquisition of CathWorks, a developer of AI‑driven coronary diagnostics. The deal builds on a 2022 co‑promotion agreement that already made the CathWorks FFRangio® System available in the U.S., Europe and Japan. FFRangio delivers...
From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
Medical device manufacturers must redesign validation strategies as prototypes transition to full‑scale production. Early validation plans often ignore equipment wear, multi‑shift operation, and material lot diversity that emerge at higher volumes. Regulatory bodies like the FDA and ISO 13485 only require...
Managing AI in Medical Technology: From Innovation to Compliance
AI is rapidly reshaping medical technology, prompting heavy investment in algorithm‑driven devices and software. At the same time, regulators worldwide are tightening oversight, creating a need for structured AI governance. The newly released ISO/IEC 42001 standard offers a lifecycle framework that...